Introduction
Introduction Statistics Contact Development Disclaimer Help
Return Create A Forum - Home
---------------------------------------------------------
MS Speaks
https://msspeaks.createaforum.com
---------------------------------------------------------
*****************************************************
Return to: PLEGRIDY (pegylated interferon beta-1a)
*****************************************************
#Post#: 519--------------------------------------------------
Plegridy to cost $62,036/year--same as Avonex
By: agate Date: October 16, 2014, 8:02 pm
---------------------------------------------------------
Excerpted from the Boston Globe, October 4, 2014:
[quote]Biogen�s new MS drug to cost $62,036 a year
By Robert Weisman | GLOBE STAFF
Cambridge biotech Biogen Idec Inc. said Friday it will charge
$62,036 per patient for a year�s treatment with its newly
approved multiple sclerosis drug Plegridy.
The list price of Plegridy, a new type of injectable drug that
treats adults with the most common form of MS, is identical to
that of Biogen Idec�s original injectable, Avonex, which is
still on the market.
Plegridy, a longer-lasting drug for patients with
relapsing-remitting MS, was approved by the Food and Drug
Administration on Aug. 15 for US sale. Biogen Idec disclosed the
price Friday before releasing the drug to distributors.
�We�re pricing for the innovation,� said Biogen Idec spokeswoman
Kate Niazi-Sai. �But we�re also pricing to make sure patients
have access to it and the system can support it. That�s a
balance, and that�s what we�re trying to do here.�
Drug pricing has become a hot button issue in an era of rising
health costs.
...
Biogen Idec�s own pill to treat MS, called Tecfidera, costs
$60,121 a year.
Plegridy, the latest addition to Biogen Idec�s portfolio of MS
medicines, also has been approved by the European Commission for
sale in 28 countries across the Atlantic.
...
Plegridy has the same active ingredient, interferon beta, as
Avonex. But the company attached a polymer called polyethylene
glycol, or peg, to Plegridy that increases the exposure of the
drug, allowing patients to take doses less frequently. While
Avonex has to be injected into the muscle once a week, Plegridy
can be taken by injection every two weeks, administered under
the skin with an auto-injector.
Biogen Idec hopes to transition many patients over time from
Avonex and other first-generation interferons, some of which
have to be injected three times a week, to the longer-lasting
drug Plegridy. But the company has no plans to discontinue the
sale of Avonex.[/quote]
The entire article can be seen here
http://www.bostonglobe.com/business/2014/10/03/biogen-idec-prices-new-multiple-…
*****************************************************
You are viewing proxied material from gopher.createaforum.com. The copyright of proxied material belongs to its original authors. Any comments or complaints in relation to proxied material should be directed to the original authors of the content concerned. Please see the disclaimer for more details.